Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2018

View Archived Issues

Renin inhibitor TAK-272 developed at Takeda for heart failure

PLIN2 is a putative tumor suppressor and prognostic marker of renal cell carcinoma

New preterm labor is drug safe with favorable pharmacokinetic profile

FDA approves Jivi for hemophilia A

Thanks for the memories: In bacteria, protein aggregates can protect from stress

Pfizer terminates two ongoing domagrozumab studies for DMD

Bristol-Myers Squibb patents receptor-interacting serine/threonine-protein kinase 1 inhibitors

Novel cardiac biomarkers identified for heart failure, myocardial infarction

Seven genes linked to plaque rupture in STEMI

Xenon Pharmaceuticals tests antiepileptic NaV1.6 inhibitors in vivo

European Commission approves Onpattro for hATTR with polyneuropathy

First patient enrolled in phase IIb/III trial of Anavex 2-73 for early Alzheimer's disease

FDA approves Merck & Co.'s Delstrigo and Pifeltro for the treatment of HIV-1

PolyActiva commences its first phase I trial of glaucoma treatment

Computational analysis uncovers mechanisms to enhance the efficacy of anti-cancer immunotherapy

MicroRNA-30c-5p identified as a potential therapeutic target and biomarker of neuropathic pain

Update on TULIP 1 phase III trial for anifrolumab in systemic lupus erythematosus

Cynata stem cell therapy meets safety and efficacy endpoints in phase I trial in GvHD

EC approves Tafinlar + Mekinist for adjuvant treatment of BRAF V600 mutation-positive melanoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...